Robin Whitsell, President and Founder of Whitsell Innovations (WI), Inc., is pleased to announce that the WI Internship Program has expanded its outreach to Postdoctoral and Doctoral scholars in life sciences. In addition to the University of North Carolina (UNC) at Chapel Hill and Duke University at Durham, WI will be presenting “Scope of Career Opportunities of Medical Communications” at the University of Colorado Denver (Anschutz Medical Campus) and the University of Pittsburgh.
Kelly Kilibarda, PhD, and Elise Eller, PhD, Medical Writers and Consultants at WI, will speak at the University of Colorado; Melissa Christianson, PhD, Medical Writer and Consultant at WI, will speak at the University of Pittsburgh; and Ms. Whitsell will speak at UNC and Duke addressing medical writing for pharmaceutical, biotech, and device companies including the documentation required for submissions to the Food and Drug Administration (FDA) during the pre-clinical and clinical development process. In addition, how industry clients use medical writers to share clinical data in manuscripts, training materials, and presentations will be discussed.
[quotes class=”quoteleft”]“We value the opportunity to be ambassadors for the life sciences industry to such talented scholars,” say Ms. Whitsell. “Speaking at these universities allows us to convey some of the career options available to scientists.”[/quotes]
ABOUT WHITSELL INNOVATIONS, INC.
WI is a WBENC-certified woman owned full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina.
Contact: info@whitsellinnovations.com
Website: www.whitsellinnovations.com
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.
###
